Cargando…

A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.

Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, A. C., Sevelda, P., Klein, M., Graf, A. H., Lahousen, M., Reiner, A., Auerbach, L., Vavra, N., Rosen, H. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968857/
https://www.ncbi.nlm.nih.gov/pubmed/8123490
_version_ 1782134832045752320
author Rosen, A. C.
Sevelda, P.
Klein, M.
Graf, A. H.
Lahousen, M.
Reiner, A.
Auerbach, L.
Vavra, N.
Rosen, H. R.
author_facet Rosen, A. C.
Sevelda, P.
Klein, M.
Graf, A. H.
Lahousen, M.
Reiner, A.
Auerbach, L.
Vavra, N.
Rosen, H. R.
author_sort Rosen, A. C.
collection PubMed
description Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68 with FTC and 194 with OC, in stage I and II were included into this study. A univariate as well as a multivariate analysis for survival was performed, including factors such as age, histological type, grading and surgical and adjuvant treatment. A significantly poorer outcome (P = 0.0002) for FTC patients with a 5-year survival of 50.8% compared with 77.5% for OC patients was observed. This finding was persistent and independent of any investigated factor, in univariate as well as multivariate analyses. Therefore, we feel that a more aggressive therapeutic approach to the treatment of FTC even in early stages can be recommended. On the other hand, the retrospective character of our study has to be taken into account.
format Text
id pubmed-1968857
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19688572009-09-10 A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Rosen, A. C. Sevelda, P. Klein, M. Graf, A. H. Lahousen, M. Reiner, A. Auerbach, L. Vavra, N. Rosen, H. R. Br J Cancer Research Article Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were able to find a distinct difference between these two tumours. A total of 262 patients, 68 with FTC and 194 with OC, in stage I and II were included into this study. A univariate as well as a multivariate analysis for survival was performed, including factors such as age, histological type, grading and surgical and adjuvant treatment. A significantly poorer outcome (P = 0.0002) for FTC patients with a 5-year survival of 50.8% compared with 77.5% for OC patients was observed. This finding was persistent and independent of any investigated factor, in univariate as well as multivariate analyses. Therefore, we feel that a more aggressive therapeutic approach to the treatment of FTC even in early stages can be recommended. On the other hand, the retrospective character of our study has to be taken into account. Nature Publishing Group 1994-03 /pmc/articles/PMC1968857/ /pubmed/8123490 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Rosen, A. C.
Sevelda, P.
Klein, M.
Graf, A. H.
Lahousen, M.
Reiner, A.
Auerbach, L.
Vavra, N.
Rosen, H. R.
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
title A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
title_full A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
title_fullStr A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
title_full_unstemmed A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
title_short A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer.
title_sort comparative analysis of management and prognosis in stage i and ii fallopian tube carcinoma and epithelial ovarian cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968857/
https://www.ncbi.nlm.nih.gov/pubmed/8123490
work_keys_str_mv AT rosenac acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT seveldap acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT kleinm acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT grafah acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT lahousenm acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT reinera acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT auerbachl acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT vavran acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT rosenhr acomparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT rosenac comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT seveldap comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT kleinm comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT grafah comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT lahousenm comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT reinera comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT auerbachl comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT vavran comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer
AT rosenhr comparativeanalysisofmanagementandprognosisinstageiandiifallopiantubecarcinomaandepithelialovariancancer